Total Payments
$1,061
2024 Payments
$153.77
Companies
9
Transactions
62
Medicare Patients
295
Medicare Billing
$27,252
Payment Breakdown by Category
Food & Beverage$1,010 (95.2%)
Education$51.12 (4.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,010 | 58 | 95.2% |
| Education | $51.12 | 4 | 4.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $248.63 | 13 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $184.92 | 9 | $0 (2023) |
| Supernus Pharmaceuticals, Inc. | $164.55 | 8 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $154.60 | 16 | $0 (2019) |
| Otsuka America Pharmaceutical, Inc. | $107.40 | 6 | $0 (2018) |
| Allergan Inc. | $76.51 | 4 | $0 (2019) |
| Vanda Pharmaceuticals Inc. | $56.26 | 2 | $0 (2021) |
| Neurocrine Biosciences, Inc. | $48.07 | 3 | $0 (2018) |
| Indivior Inc. | $20.12 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $153.77 | 10 | ABBVIE INC. ($137.80) |
| 2023 | $146.40 | 7 | Supernus Pharmaceuticals, Inc. ($58.89) |
| 2022 | $70.76 | 3 | Janssen Pharmaceuticals, Inc ($41.25) |
| 2021 | $211.67 | 9 | Supernus Pharmaceuticals, Inc. ($89.69) |
| 2020 | $26.25 | 1 | Vanda Pharmaceuticals Inc. ($26.25) |
| 2019 | $60.27 | 4 | Sunovion Pharmaceuticals Inc. ($41.53) |
| 2018 | $247.93 | 18 | Otsuka America Pharmaceutical, Inc. ($67.03) |
| 2017 | $144.01 | 10 | Sunovion Pharmaceuticals Inc. ($58.17) |
All Payment Transactions
62 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: NEUROSCIENCE | ||||||
| 06/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $34.16 | General |
| Category: NEUROSCIENCE | ||||||
| 05/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.50 | General |
| Category: NEUROSCIENCE | ||||||
| 05/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.82 | General |
| Category: NEUROSCIENCE | ||||||
| 05/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.77 | General |
| Category: NEUROSCIENCE | ||||||
| 04/05/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 03/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: NEUROSCIENCE | ||||||
| 02/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.46 | General |
| Category: NEUROSCIENCE | ||||||
| 02/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.90 | General |
| Category: NEUROSCIENCE | ||||||
| 01/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.70 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $21.70 | General |
| Category: PSYCHOLOGY | ||||||
| 11/14/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.92 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $23.69 | General |
| Category: PSYCHOLOGY | ||||||
| 06/20/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Neuroscience | ||||||
| 06/13/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: Neuroscience | ||||||
| 03/27/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Neuroscience | ||||||
| 02/20/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $13.50 | General |
| Category: PSYCHOLOGY | ||||||
| 07/12/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $25.87 | General |
| Category: Neuroscience | ||||||
| 06/14/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.51 | General |
| Category: NEUROSCIENCE | ||||||
| 06/10/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Neuroscience | ||||||
| 12/09/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: NEUROSCIENCE | ||||||
| 11/24/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: PSYCHOLOGY | ||||||
| 10/29/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $22.86 | General |
| Category: PSYCHOLOGY | ||||||
| 09/22/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $29.69 | General |
| Category: PSYCHOLOGY | ||||||
| 09/01/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.45 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 51 | 109 | $8,286 | $5,164 |
| 2022 | 3 | 80 | 153 | $11,210 | $6,871 |
| 2021 | 3 | 81 | 188 | $13,581 | $8,577 |
| 2020 | 4 | 83 | 152 | $10,548 | $6,640 |
Total Patients
295
Total Services
602
Medicare Billing
$27,252
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 60 | $5,451 | $3,325 | 61.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 49 | $2,835 | $1,840 | 64.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 34 | 83 | $7,561 | $4,547 | 60.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 34 | 55 | $3,202 | $2,017 | 63.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 12 | 15 | $446.42 | $306.64 | 68.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 36 | 94 | $8,624 | $5,118 | 59.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 32 | 75 | $4,406 | $3,108 | 70.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 13 | 19 | $551.57 | $349.88 | 63.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 31 | 70 | $6,677 | $4,300 | 64.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 20 | 35 | $2,161 | $1,317 | 61.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 13 | 20 | $849.24 | $555.56 | 65.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 19 | 27 | $860.75 | $466.96 | 54.3% |
About Dr. Iustinian Rusu, M.D
Dr. Iustinian Rusu, M.D is a Psychiatry healthcare provider based in Rochester, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2009. The National Provider Identifier (NPI) number assigned to this provider is 1962631234.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Iustinian Rusu, M.D has received a total of $1,061 in payments from pharmaceutical and medical device companies, with $153.77 received in 2024. These payments were reported across 62 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($1,010).
As a Medicare-enrolled provider, Rusu has provided services to 295 Medicare beneficiaries, totaling 602 services with total Medicare billing of $27,252. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Child & Adolescent Psychiatry
- Location Rochester, NY
- Active Since 07/08/2009
- Last Updated 10/29/2014
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1962631234
Products in Payments
- VRAYLAR (Drug) $325.14
- LATUDA (Drug) $154.60
- QELBREE (Drug) $148.58
- INVEGA SUSTENNA (Drug) $143.31
- HETLIOZ (Drug) $56.26
- REXULTI (Drug) $56.12
- ABILIFY MAINTENA (Drug) $51.28
- INGREZZA (Drug) $48.07
- SPRAVATO (Drug) $41.61
- PERSERIS (Drug) $20.12
- Qelbree (Drug) $15.97
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Rochester
Mr. Tulio Ortega, Md, MD
Psychiatry — Payments: $246,543
Psychiatry $246,543
M Ismail, M.d, M.D
Psychiatry — Payments: $50,839
Psychiatry $50,839
Syed Mustafa, Md, MD
Psychiatry — Payments: $26,048
Psychiatry $26,048
Peter Jensen, Md, Abpn, MD, ABPN
Psychiatry — Payments: $19,612
Psychiatry $19,612
Daniel Montville, Md, MD
Psychiatry — Payments: $15,131
Psychiatry $15,131
Mark Frye, Md, MD
Psychiatry — Payments: $12,930
Psychiatry $12,930